Interest in {dimethyltryptamine | copyright | this substance ) is definitely sparking a growing discussion across Canada. Until recently considered the fringes of study , copyright is now attracting wider attention from researchers , clinicians, and the community. Legal frameworks surrounding its potential administration – particularly in therape